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Edited by Masayuki MiyasakaAbstract Three slit genes, slit1 to slit3, have been cloned to
date. Slit1 and slit2 act as chemorepellent factors for axon guid-
ance. Slit3 is involved in the formation of the diaphragm and kid-
ney during embryogenesis. However, its molecular function
remains unclear. We found that slit3 expression was induced
by lipopolysaccharide (LPS)-stimulation in macrophages and
that it was localized in the mitochondria and along the plasma
membrane. Silencing of slit3 expression by RNA interference
reduced cell motility and Rac/Cdc42 activation. These results
suggest that slit3 functions as an intracellular signaling molecule
for cell motility as part of the LPS-induced signaling cascade.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Slit is a secreted protein that is involved in midline pattern-
ing in Drosophila [1]. Three vertebrate orthologs of the fruit ﬂy
slit gene, slit1, 2, and 3, have been isolated. Each gene exhibits
overlapping, but distinct patterns of expression in the verte-
brate nervous system [2–4]. Slit1 and slit2 are known to be se-
creted from glial cells to regulate axonal pathﬁndings [3–5].
These slit genes have been shown to be expressed in non-neu-
ronal tissues [2,6]. Interestingly, Little et al. reported that slit3
is localized within the mitochondria in kidney epithelial cells
and is transported to the cell surface in conﬂuent epithelial
monolayers [7]. It has also been reported that slit3 is involved
in diaphragm development and kidney formation during
embryogenesis [8]. The secretion and function of slit3 is still
uncertain.
Lipopolysaccharide (LPS) is an outer membrane component
of Gram-negative bacteria that is recognized by most cell
types, but its eﬀects are primarily mediated by cells of the im-
mune system, such as macrophages [9]. LPS signaling is asso-
ciated with the cellular membrane receptor, Toll-like receptor
(TLR) 4, which contains an intracellular signaling domain [10].
LPS aﬀects the cell spreading of macrophages [11–13]. The
process of cell spreading to acquire a ﬂattened morphology in-*Corresponding author. Fax: +81 72 254 9489.
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trolled by Rac and Cdc42. These mediators act as binary
switches that cycle between active GTP-bound and inactive
GDP-bound states to regulate actin organization [14]. In cell
spreading, Rac stimulates the formation of sheet-like exten-
sions, called lamellipodia or membrane ruﬄes, whereas
Cdc42 stimulates formation of long, thin extensions called ﬁl-
opodia [15].
In this study, we report that slit3 expression is stimulated by
LPS-treatment in macrophages. Slit3 is predominantly local-
ized in both mitochondria and cell membrane and contributes
to cell motility through Rac/Cdc42 activity.2. Materials and methods
2.1. Cell culture
Macrophages were obtained by lavage of mouse peritoneal cavities
and puriﬁed by the adherence to bottom of culture dish [16]. Adherent
cells were stimulated with 100 ng/ml LPS from Escherichia coli strain
O26:B6 (Sigma, St. Louis, MO). The RAW264.7 mouse macrophage
cell line was maintained in DMEM supplemented with 10% FBS and
50 lg/ml gentamicin. Cells (5 · 105) were cultured overnight on a
35 mm culture dish and then stimulated with 100 ng/ml LPS.2.2. RT-PCR
Total RNA was isolated from the cultured cells, reverse transcribed
to cDNA, and ampliﬁed with the following primer pairs for mouse
slit1; 5 0-GCCGAAAACTCTACTGTCT-3 0 and 5 0-GGGCTTCTCC-
ACCTCCTCA-30, for mouse slit2; 5 0-CATATTACTGTGTTGAGCA-
TCTCTCC-3 0 and 5 0-TACTGGTTACTTACTCTGCTTCAGACC-30,
for mouse slit3; 5 0-CTAAACCAGACCCTGAACCTGGTGGTAGA-
C-3 0 and 5 0-AAGGTAGAGGGGGCTGTTGCTGCCCACT-3 0, for
mouse TNFa; 5 0-AACTTCGGGGTGATCGGTCC-3 0 and 5 0-CAAA-
TCGGCTGACGGTGTGGG-3 0, for mouse IL-1b; 5 0-GGAATCTG-
TGTCTTCCTAAAGTATGG 0 and 5 0-ATAAATAGGTAAGTGGT-
TGCCCATC-30.
2.3. Plasmid constructs and transfection
For RNAi, 5 parts of target on mouse slit3 sequence (GenBank No.
NM_011412) for slit3-RNAi were selected by siRNA Wizard v2.5
(Invivogen, San Diego, CA). Each oligonucleotide was cloned into
psiRNA-hH1GFPzeo (Invivogen), and produced short hairpin slit3-
speciﬁc small interfering RNAs in RAW264.7 cells. The cells were
transfected using Lipofectamine 2000 (Invitrogen, Carlsbad, CA), se-
lected with Zeocin (Invivogen) and transfection was conﬁrmed through
GFP observation. A construct which showed most eﬀective suppres-
sion of slit3 expression conﬁrmed by RT-PCR was selected (56-mer
slit3-speciﬁc oligonucleotide: 5 0-ACCTCAAAGGACGTGACTGA-
ACTGTATCAAGAGTACAGTTCAGTCACGTCCTTTTT-3 0). The
scramble oligonucleotide: 5 0-ACCTCGGAGAACGACCAAGATG-
TATTTCAAGAGAATACATCTTGGTCGTTCTCCTT-3 0 was gen-
erated for the control plasmid.blished by Elsevier B.V. All rights reserved.
Fig. 1. LPS stimulation induces slit3 mRNA expression in primary
mouse peritoneal macrophages. (A) The macrophages were cultured
for the indicated periods of time with or without 100 ng/ml LPS. (B)
The cells were treated with 10, 100, or 1000 ng/ml LPS for 2 h and
analyzed by RT-PCR.
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The cells were incubated with lysis buﬀer (20 mM Tris–HCl, pH 7.5,
150 mM NaCl, 1% Triton X-100, and a proteinase inhibitor cocktail
(Sigma)). The supernatant was subjected to immunoblot analysis con-
ducted using the anti-slit3 (Santa Cruz Biotechnology, Santa Cruz,
CA) or anti- b-tubulin (Sigma) antibodies. An Immunostar kit (Wako
Pure Chemical Industries, Osaka, Japan) was used for detection. For
analysis of slit3 secretion, the cultured supernatant and high-salt wash
(1 M NaCl, 10 mM HEPES, pH 7.5) of the cells were collected as a se-
creted protein fraction [5]. The mixture of the supernatant and the salt
wash, and the cell lysate were subjected to immunoblot. As a positive
control of secretion from the cells, a constructs containing slit1 tagged
with FLAG were transfected into the cells and secreted protein was de-
tected with an anti-FLAG M2 antibody.
2.5. Immunoﬂuorescence staining
Cells were cultured onto a poly-L-lysine-coated coverslip (Asahi
Techno Glass, Tokyo, Japan) and treated with 100 ng/ml LPS for
8 h. After the ﬁxing, the coverslip was incubated with the anti-slit3
antibody. After washing, the coverslip was incubated with a FITC-
conjugated rabbit anti-goat IgG (Sigma), and examined using a ﬂuo-
rescence diﬀerential interference microscope (Olympus, Tokyo, Japan).
Mitochondria was stained with Mitotracker Red CMXRos (Invitro-
gen) and F-actin was stained with Rhodamine–phalloidin (Invitrogen).
2.6. Spreading assay
The cells cultured on the coverslip were stimulated with 100 ng/ml
LPS for 8 h. Two hundred cells were counted per coverslip under a
phase contrast diﬀerence microscope, and the percentage of spreading
cells, as identiﬁed by ﬂat and spreading cell morphology [17], was cal-
culated. All experiments were repeated at least three times. Cells trans-
fected with the RNAi vectors containing GFP gene were conﬁrmed by
GFP observation under a ﬂuorescence microscope.
2.7. Rac/Cdc42 activation assay
The cells were treated with 100 ng/ml LPS for 8 h and then Rac/
Cdc42 activation assays were performed using a Rac/Cdc42 activation
assay kit (Chemicon, Temecula, CA), according to the manufacturer’s
protocol.
2.8. Wound-healing assay
RAW264.7 cells were seeded on the coverslip, grown to 70% conﬂu-
ence, and wounds were carefully made (350–400 lm) across the mono-
layer cells, using a micropipette tip. The cells were incubated with or
without 100 ng/ml LPS for 24 h.3. Results
3.1. Slit3 expression in LPS-stimulated macrophage
The presence of slit3 mRNA in mouse peritoneal macro-
phages following stimulation with LPS was conﬁrmed by
RT-PCR (Fig. 1). The sequence of the PCR product corre-
sponded to the sequence for mouse slit3 (GenBank No.
NM_011412). Although the expression of slit3 mRNA in the
absence of LPS was low but detectable, there were obvious
increases of slit3 mRNA in the peritoneal macrophages within
2 h after LPS treatment (Fig. 1A). The increase in slit3 mRNA
was dependent on the concentration of LPS (Fig. 1B). These
results suggest that LPS stimulation induces the expression
of slit3 in primary macrophages.
3.2. Expression of slit3 in RAW264.7 macrophages stimulated
with LPS
To examine the function of slit3 in macrophages, we used a
mouse macrophage cell line, RAW264.7. The expression of
slit3 mRNA in RAW264.7 cells stimulated with LPS was con-
ﬁrmed by RT-PCR. There were marked increases in slit3
mRNA for 2–6 h after the LPS stimulation, although theexpression of slit3 mRNA was low in the absence of LPS
(Fig. 2A). To investigate the other slits mRNA expression
(slit1 and slit2) in the cells, RT-PCR for slit1 (GenBank No.
NM_015748) and slit2 (GenBank No. NM_0178804) mRNA
were performed at the same condition. The expression of slit1
and slit2 were background level (Fig. 2A). Real-time PCR re-
vealed that the increase in slit3 mRNA in the presence of LPS
was approximately 7 times that in the absence of LPS
(Fig. 2B). To conﬁrm the presence of slit3 protein in the cells,
immunoblot analysis was performed using an anti-slit3 anti-
body. Slit3 protein was detected in the LPS-activated cells
and was increased for 4–10 h (Fig. 2C). These results indicate
that LPS stimulation induced slit3 expression, not slit1 and
slit2 expression, in RAW264.7 cells.
3.3. Subcellular localization of slit3 in RAW264.7 macrophages
To determine whether slit3 is secreted from RAW264.7 cells,
presence of slit3 in mixture of the cultured supernatant and the
high-salt wash of the cell elicited by LPS was examined by
immunoblot with the anti-slit3 antibody (Fig. 3A). Slit3 was
detected in the cell lysate under LPS stimulation. On the other
hand, slit3 was not detected in the mixture with or without
LPS-stimulation. FLAG-tagged slit1, known to be secreted
into culture medium [3], was detected both in the cell lysate
and the mixture of supernatant and salt wash. The results indi-
cate that slit3 is not secreted from the cells. The subcellular
localization of slit3 in RAW264.7 cells was investigated by
immunoﬂuorescence with the slit3 antibody (Fig. 3B; b) and
co-labeling with Mitotracker labeling for mitochondria
(Fig. 3B; c) using a diﬀerential interference microscope. Slit3
was detected around the nucleus, and exhibited similar distri-
bution to the mitochondria. Slit3 was also detected along the
plasma membrane in the spreading cells stimulated with LPS
(Fig. 3C; b). Rhodamine-phalloidin was used to stain F-actin
in cells co-labeled with the slit3 antibody (Fig. 3C; c). Most
of the slit3 along the membrane was colocalized with F-actin.
3.4. Slit3 is required for LPS-induced spreading of RAW264.7
macrophages
RAW264.7 cells were transfected with a slit3-RNAi vector
that produces siRNA targeted speciﬁcally against slit3. RT-
PCR and immunoblot analysis with slit3 antibody (Fig. 4A)
Fig. 2. Slit3 expression in RAW264.7 cells stimulated with LPS. Cells
were cultured in the presence or absence of LPS (100 ng/ml) for the
indicated periods of time. (A) RT-PCR analysis of slit1, slit2, and slit3
expression. (B) The relative expression levels of slit3 were assessed by
real time-PCR analysis. Quantitative results of data from individual
processes in the presence of LPS (n = 3) or absence of LPS (n = 3). (C)
Immonoblot analysis for slit3 protein in the cells. Immunoblotting
with the anti-tubulin antibody indicates that an equal amount of
protein was loaded in each lane.
Fig. 3. Localization of slit3 protein in RAW264.7 cells. (A) Immuno-
blot analysis for slit3 secretion. The cells were treated with or without
LPS. The cultured supernatant and the high-salt wash were mixed
(SW) and the cells were lysed (CL). Slit3 and slit1-tagged with FLAG
were probed by anti-slit3 antibody and anti-FLAG antibody, respec-
tively. (B) Diﬀerential interference microscope image. Cells were
stimulated with LPS (a–c) or incubated without LPS (d–f). Immuno-
ﬂuorescence with slit3 antibody (b,e) and merged images with
Mitotracker labeling for mitochondria (c,f). Merged images demon-
strate colocalization of slit3 with the mitochondria (arrow). (C) The
cells were stimulated with (a–c) or without (d–f) LPS. Immunoﬂuo-
rescence with slit3 antibody (b,e) and merged images with rhodamine-
phalloidin labeling of F-actin (c,f). Merged image demonstrates
colocalization of slit3 with F-actin (arrow).
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transfected cells treated with LPS. LPS has known to induce
secretion of inﬂammatory cytokines, such as TNFa and IL-
1b, from macrophage [18]. To conﬁrm the eﬀect of slit3
inhibition by the RNAi to the transcription of these cytokines,
RT-PCR for mouse TNFa (GenBank No. NM_013693) and
mouse IL-1b (GenBank No. NM_008361) genes were per-
formed with the cells under LPS stimulation. Slit3-RNAi did
not aﬀect the expression of TNFa and IL-1b, in the cells
(Fig. 4B). Slit3-RNAi inhibited the spreading of the LPS-trea-
ted cells, as compared to the morphological changes in the con-
trol vector transfected cells (Fig. 4C; a, c). Slit3-RNAi reduced
the degree of the spreading cells from 70% to the basal level
(Fig. 4D). These results suggest that slit3 is required for
LPS-induced spreading of RAW264.7 cells.
3.5. Slit3 is involved in LPS-induced Rac and Cdc42 activation
Activation of the small-GTPases, Rac and Cdc42, is in-
volved in actin cytoskeletal organization leading to cell spread-ing and migration [14,15]. We investigated the activation of
Rac and Cdc42 in slit3-RNAi transfected cells. Slit3-RNAi
downregulated the LPS-induced activation of Rac and
Cdc42, compared with activation of the control vector trans-
fected cells (Fig. 5A and B). Furthermore, to evaluate the
motility of the slit3-RNAi transfected cells, a wound-healing
assay was performed. The slit3-RNAi transfected cells did
not ﬁll the open space of the wound, although the control vec-
tor transfected cells ﬁlled the entire open space (Fig. 5C). These
results indicate that slit3 is required for LPS-induced cell
spreading and migration through Rac and Cdc42 activation.
Fig. 4. Eﬀect of slit3-RNAi on the spreading of RAW264.7 cells. (A) RT-PCR and immunoblot analysis for slit3 expression in cells transfected with
or without the slit3-RNAi vector. Cells were stimulated with or without LPS. (B) RT-PCR analysis of slit3, TNFa, and IL-1b expression. (C) The
cells transfected with the control vector (a) or the slit3-RNAi construct (c) were stimulated with LPS. Cells transfected with the vectors containing
GFP gene were conﬁrmed by GFP observation (b, d). (D) The cells transfected with or without the RNAi vector were ﬁxed, and the percentage of cell
spreading was determined. Results are from one of three independent experiments (means ± S.E.M.).
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It has been reported that slit3 is expressed in many cell
lines [7], and the expression is high in the kidneys, skeletal
muscle, and heart, both during development and postnatal
stage [19]. However, the function of slit3 in the cells and tis-
sues is not well established. We demonstrated that slit3 expres-
sion was induced by LPS treatment in primary macrophages
and RAW264.7 cells (Figs. 1,2). The eﬀects of LPS are primar-
ily mediated by cells of the immune system, such as macro-
phages [9]. LPS stimulates an intracellular signaling pathway
through TLR4 [10]. It is suggested that slit3 is involved in
the inﬂammatory signaling system induced by LPS in macro-
phages.
Slit3 was not secreted from RAW264.7 cells (Fig. 3A) and it
was localized in mitochondria of the LPS-stimulated
RAW264.7 cells (Fig. 3B). It has been reported that subcellular
distribution of mammalian slit3 was within the mitochondria,
since slit3 exhibits a mitochondrial targeting signal on the N-
terminal sequence [7]. The function of slit3 within mitochon-
dria remains unknown, and proteins interacted with slit3 have
not been identiﬁed. We were not able to detect expression of
robo1 or robo2, which are known receptors for slit proteins,
in the LPS-activated RAW264.7 cells (data not shown). These
results suggest that slit3 may interact with molecules other
than the robo receptors in macrophages.
It has been also shown that slit3 is transported to the cell
surface in conﬂuent epithelial monolayers [7]. Slit3 appeared
along the plasma membrane of the LPS-activated RAW264.7cells and was colocalized with F-actin (Fig. 3C). Slit3-RNAi
inhibited spreading of RAW264.7 cells following LPS treat-
ment (Fig. 4). LPS stimulation changes macrophage morphol-
ogy, so that it assumes a ﬂat and spreading shape [17]. The
process of morphological alteration involves complex dynamic
reorganization of the actin cytoskeleton [14,15]. Slit3 may be
involved in cell spreading via actin reorganization induced
by LPS signaling.
LPS-induced cell spreading and migration were reduced in
the slit3-RNAi transfected cells (Figs. 4 and 5C). Actin cyto-
skeletal organization is known to be regulated by Rac and
Cdc42 [14]. Activation of these mediators was reduced in the
slit3-RNAi transfected cells stimulated by LPS (Fig. 5A and
B). The activation of Rac and Cdc42 triggers the formation
of membrane ruﬄing and ﬁlopodial protrusions required for
cell spreading and migration [15]. LPS stimulation also induces
secretion of inﬂammatory cytokines, such as TNFa, IL-1b
from macrophage [18]. Slit3-RNAi had no eﬀect on the tran-
scription of TNFa and IL-1b genes (Fig. 4B). These results
suggest that slit3 functions upstream of Rac/Cdc42 signaling
to regulate cell migration without any eﬀects of the inﬂamma-
tion mediators.
The pathogenesis of cancer is characterized by changes in
cell growth, diﬀerentiation, invasion and metastasis. Constitu-
tive activation of Rac and Cdc42 causes upregulation of cell
migration, leading to invasion and metastasis of cancer cells
[20]. It has been reported that slit3 expression was increased
in several prostate tumors [21], and that epigenetic activation
of slit3 was observed in lung and breast cancer [22]. It might
Fig. 5. Eﬀect of slit3-RNAi on Rac and Cdc42 activation. (A and B)
The cells transfected with the control vector or the slit3-RNAi
construct were cultured in the presence or absence of LPS. (C) The
cells were incubated for 24 h. The images were photographed under
phase contrast (a, c) and ﬂuorescent light (b, d). Cells transfected with
the RNAi vectors including the GFP gene, were conﬁrmed by GFP
observation. Photographs of results are from one of three independent
experiments.
1026 T. Tanno et al. / FEBS Letters 581 (2007) 1022–1026be possible to develop a new therapeutic agent to target slit3
function, in the treatment of metastatic malignant tumors.
In summary our data is the ﬁrst to characterize the molecu-
lar function of Slit3. The expression of slit3 in macrophages is
stimulated by LPS. Slit3 is localized both in mitochondria and
along cell membrane of RAW264.7 cells and regulates cell
spreading and migration through Rac/Cdc42 GTPases activity
following LPS stimulation. Further studies will be required to
determine the precise molecular mechanism of cell motility
concerned with slit3 in macrophages.
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